Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee H Martin

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
BMC Medical Research Methodology|August 19, 2020
Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsJunhao Liu, Jo Wick, Renee' H Martin, et al.
BMC Medical Research Methodology|September 11, 2020
Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsJunhao Liu, Jo Wick, Renee' H Martin, et al.
Communications in Statistics: Simulation and Computation|December 12, 2017
Assessing type I error and power of multistate Markov models for panel data-A simulation studyChristy Cassarly, Renee' H Martin, Marc Chimowitz, et al.
Journal of Biopharmaceutical Statistics|July 10, 2018
Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scaleChristy Cassarly, Renee' H Martin, Marc Chimowitz, et al.
Plos One|October 27, 2017
Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trialChristy Cassarly, Renee' H Martin, Marc Chimowitz, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 25, 2020
Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS TrialEyad Almallouhi, Sami Al Kasab, Lidia Yamada, et al.
BMC Endocrine Disorders|June 20, 2018
Determining the joint effect of obesity and diabetes on functional disability at 3-months and on all-cause mortality at 1-year following an ischemic strokeColleen Bauza, Sharon D Yeatts, Keith Borg, et al.
Contemporary Clinical Trials|March 11, 2014
Continuous covariate imbalance and conditional power for clinical trial interim analysesJody D Ciolino, Renee' H Martin, Wenle Zhao, et al.
Stroke|July 28, 2016
ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2Renee' H Martin, Sharon D Yeatts, Michael D Hill, et al.
Statistics in Medicine|November 5, 2023
Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distributionVirginia B Shipes, Caitlyn Meinzer, Bethany J Wolf, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
BMC Medical Research Methodology|August 19, 2020
Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsJunhao Liu, Jo Wick, Renee' H Martin, et al.
BMC Medical Research Methodology|September 11, 2020
Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsJunhao Liu, Jo Wick, Renee' H Martin, et al.
Communications in Statistics: Simulation and Computation|December 12, 2017
Assessing type I error and power of multistate Markov models for panel data-A simulation studyChristy Cassarly, Renee' H Martin, Marc Chimowitz, et al.
Journal of Biopharmaceutical Statistics|July 10, 2018
Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scaleChristy Cassarly, Renee' H Martin, Marc Chimowitz, et al.
Plos One|October 27, 2017
Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trialChristy Cassarly, Renee' H Martin, Marc Chimowitz, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 25, 2020
Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS TrialEyad Almallouhi, Sami Al Kasab, Lidia Yamada, et al.
BMC Endocrine Disorders|June 20, 2018
Determining the joint effect of obesity and diabetes on functional disability at 3-months and on all-cause mortality at 1-year following an ischemic strokeColleen Bauza, Sharon D Yeatts, Keith Borg, et al.
Contemporary Clinical Trials|March 11, 2014
Continuous covariate imbalance and conditional power for clinical trial interim analysesJody D Ciolino, Renee' H Martin, Wenle Zhao, et al.
Stroke|July 28, 2016
ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2Renee' H Martin, Sharon D Yeatts, Michael D Hill, et al.
Statistics in Medicine|November 5, 2023
Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distributionVirginia B Shipes, Caitlyn Meinzer, Bethany J Wolf, et al.
Pageof 7